In Vitro Ubiquitination Assay

KZ Khalequz Zaman
JK Julia Knight
FH Faraaz Hussain
RC Ruofan Cao
SE Samuel K. Estabrooks
GA Ghaith Altawallbeh
KH Kristopher Holloway
AJ Anjum Jafri
VS Victoria Sawczak
YL Yuejin Li
PG Paulina Getsy
FS Fei Sun
TR Thomas Raffay
CC Calvin Cotton
JB Jeffrey L. Brodsky
AP Ammasi Periasamy
SL Stephen J. Lewis
BG Benjamin Gaston
request Request a Protocol
ask Ask a question
Favorite

An in vitro ubiquitination assay was performed as previously described (42). Briefly, ubiquitination reaction mixtures were prepared first by combining 0.125 μM E1 (Ube1) and 1 μM E2 (UbcH5b) (Boston Biochem), 200 μM ubiquitin (Sigma), and the appropriate volume of 10× reaction buffer (50 mM HEPES, pH 7.0, 50 mM NaCl, 20 mM ATP, 40 mM MgCl2), followed by a 30-minute incubation at 37°C. In parallel, a total of 3 μM of purified CHIP was combined on ice with Hsc70 substrate recognition domain (GST-Hsc70395-646) in 50 mM HEPES (pH 7.0) and 50 mM NaCl. Control reactions were also set up in the absence of ATP. After addition of the two mixtures, the reactions were incubated for 1 hour at 20°C and then stopped by the addition of SDS-PAGE sample buffer supplemented with 50 mM EDTA. The quenched reactions were resolved by SDS-PAGE, transferred onto nitrocellulose membranes, and probed with either anti-GST HRP-conjugated antibody (Abcam) or anti-ubiquitin (catalog no. SC: 8017; Santa Cruz Biotechnology), which was detected with horse anti-mouse-HRP antibody (Cell Signaling). The concentrations provided for all purified proteins used in the reactions reflect their final reaction concentrations.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A